Understanding how the immune system fights human coronaviruses
Innate immune factors governing restriction of human coronaviruses
This study is looking at how our body's first defense against viruses, called Type I interferon, reacts to different types of coronaviruses, to help understand why some make us very sick while others only cause mild symptoms, with the hope of finding better treatments for everyone.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10673163 on NIH RePORTER |
What this research studies
This research investigates the innate immune response to different human coronaviruses, particularly focusing on how the immune system's first line of defense, known as Type I interferon, reacts to both severe and mild strains of the virus. By identifying specific immune factors that restrict these viruses, the research aims to uncover why some coronaviruses cause severe illness while others lead to mild symptoms. The study employs high-throughput screening methods to analyze immune responses and aims to discover new antiviral strategies. Patients may benefit from insights that could lead to improved treatments for coronavirus infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been infected with or are at risk of infection from human coronaviruses, particularly those with severe symptoms.
Not a fit: Patients who have not been infected with coronaviruses or those with mild, non-complicated infections may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral therapies that enhance the immune response against coronaviruses.
How similar studies have performed: Previous research has shown promise in understanding immune responses to coronaviruses, but this study aims to explore novel aspects that have not been comprehensively addressed.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Stoddard, Caitlin — Fred Hutchinson Cancer Center
- Study coordinator: Stoddard, Caitlin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.